A Review on Bioactive Compounds Isolated from Euphorbia hirta L.
Roland Nâg-Tiéro Meda1, Sami Eric Kam1,2*, Windmi Kagambega1, Eliasse Zongo1, Clarisse Ouedraogo1, Abdoulaye Segda1, Benjamin Kouliga Koama1,3, Franck Téounviel Somda1, Emmanuel Zongo1,4, Georges Anicet Ouedraogo1
1Laboratoire de Recherche et d’Enseignement en Santé et Biotechnologies Animales, Université Nazi BONI, Bobo-Dioulasso, Burkina Faso.
2Laboratoire de Recherche en Biochimie, INSP/Centre MURAZ, Bobo-Dioulasso, Burkina Faso.
3Laboratoire de Médicine et Pharmacopée Traditionnelle, Institut de Recherche en Sciences de la Santé, Direction Régionale de Bobo-Dioulasso, Bobo-Dioulasso, Burkina Faso.
4Laboratoire de Biochimie, Centre Hospitalier Universitaire Sourou SANOU, Bobo-Dioulasso, Burkina Faso.
DOI: 10.4236/ajps.2023.146048   PDF    HTML   XML   206 Downloads   1,823 Views  

Abstract

Euphorbia hirta L. is an annual medicinal herb throughout many tropical continents used to cure various diseases. Several studies have isolated many bioactive compounds from E. hirta. This study aimed at providing a collection of bioactive constituents in E. hirta. This review summarizes the extraction solvent, the structures and the properties of 38 bioactive phytochemicals isolated from E. hirta. It could help to understand the relationship existing between phytochemicals and their activities.

Share and Cite:

Meda, R. , Kam, S. , Kagambega, W. , Zongo, E. , Ouedraogo, C. , Segda, A. , Koama, B. , Somda, F. , Zongo, E. and Ouedraogo, G. (2023) A Review on Bioactive Compounds Isolated from Euphorbia hirta L.. American Journal of Plant Sciences, 14, 710-726. doi: 10.4236/ajps.2023.146048.

1. Introduction

Medicinal plants are used worldwide for the treatment of various diseases and disorders. Euphorbia L. (Euphorbiaceae) is the third largest genus of flowering plants, with rich pharmacological properties, and Euphorbia hirta L. is the species with the most useful records [1] . E. hirta is an annual medicinal herb with various medicinal properties, and it is distributed in many tropical continents (Asia, America and Africa) [2] . Indeed E. hirta is used widely in traditional Malay medicine to cure skin problems, amoebic dysentery, diarrhea, and ulcer [3] . In Nigeria, the exudates of the stem extracts of E. hirta have given satisfactory results in earache treatment [4] . In Burkina Faso, this plant is also used to treat digestive unrest, pregnancy-birth disorders, bacterial infections, diabetes, hypertension, visual disturbances, scorpion sting, parasitosis and allergies [2] [5] [6] . Pharmacological studies showed that extracts of E. hirta exerted antioxidant, antimicrobial, sedative anxiolytic, antiepileptic, anti-inflammatory, analgesic, antipyretic, antihistaminic, antiasthmatic, antidiabetic, anticancer, wound healing, gastrointestinal, diuretic, antiparasitic, immunological, hepatoprotective, galactogenic, angiotensin-converting enzyme inhibiting and anti-dipsogenic activities [7] [8] . Secondary metabolites such as flavonoids, steroids, terpenoids, coumarins, tannins, and polyphenols were isolated from E. hirta and characterized [9] [10] . Numerous active constituents from E. hirta with its pharmacological actions have been investigated by many researchers. However, few studies have listed these molecules and their properties [8] [9] [10] . The current review will summarize the most recent information on the compounds isolated from extracts of E. hirta, as well as its structures, pharmacological effects, mechanism of action and dosage efficiency.

2. Method

The present review covered the literature published prior to the year 2022. The information about Phytochemicals from E. hirta and its pharmacological properties was gathered from search engines like Google Scholar, NCBI, Scientific Research and Science Direct. Literature abstracts and full-text articles available from scientific revues were analyzed and bioactive compounds extracted from E. hirta were included in this review.

3. Taxonomy of Euphorbia hirta

Classification, according to Rhasid et al. [11] :

Kingdom: Plantae;

Phylum: Magnoliophyta;

Class: Angiospermae;

Order: Malpighiales;

Family: Euphorbiaceae;

Genus: Euphorbia;

Species: hirta.

4. Morphology

E. hirta is a slender-stemmed, annual hairy plant, spreading up to 40 cm in height, reddish or purplish in color, with many branches from the base to summit Photo 1. The leave with 1 - 2.5 cm long is opposite, elliptic-oblong to oblong-lanceolate, acute or subacute, dark green above, pale beneath. The fruits are yellow, three-celled, hairy, keeled capsules, 1 - 2 mm in diameter, containing three brown, four-sided, angular, wrinkled seeds [10] .

5. Distribution

Also called Euphorbia capitata Lam. or Euphorbia pilulifera Jacq. or Chamaesyce

Photo 1. View of Euphorbia hirta L. (Kam, 2022): (a) Whole plant; (b) Fruits and leaves of plant.

hirta (L.) Millsp, E. hirta L. is distributed throughout America, Africa, Asia and Australasia. It is often found in waste places along the roadsides [7] [10] .

6. Bioactive Compounds Isolated from E. hirta

The fractionation, chromatographic separation and purification of different extracts of E. hirta have offered thirty-eight bioactive phytoconstituents. The sources, molecule class and solvents used for molecule extraction are organized in Table 1.

Phenolic constituents [12] , including flavonoids [10] , Phenolic acids [13] and tannins [14] , are the most represented class of bioactive molecules extracted. Furthermore, ten bioactive terpenoids from extracts were also obtained. Different parts of the plant were used to process the extractions. Aerial part and whole plant were frequently employed, and methanol was the most extraction solvent used, followed by ethanol.

7. Structures of Bioactive Phytochemicals Isolated

Most of the structures of bioactive phytochemicals in E. hirta were downloaded from PubChem database. The models of unknown structures were built on the ACDLabs202020_ChemSketch software. The structures of 38 drug molecules are illustrated in Figure 1.

8. Biological Potential of Phytochemical

The bioactive compounds isolated from E. hirta, have demonstrated fourteen biological activities recorded. Table 2 presents mechanisms of action of compounds

Table 1. Phytochemicals isolated from E. hirta.

Figure 1. Structure of 38 bioactive components suggested from PubChem

Table 2. Mechanisms of compounds isolated from E. hirta.

isolated from E. hirta. Quercetrin following by quercetin and β-amyrine were the most characterized biomolecules. They had properties such as anti-diabetes, anti-inflammatory, antimalarial, anticancer, anti-snake venom, antimicrobial, antidiarrhoeic and antistress. Otherwise, not identified lignans from ethanol extract of E. hirta has demonstrated an anticancer activity against cell lines Hep G2 with IC50 value of 7.2 ± 0.17 and 8.5 ± 0.36 µM [40] . The peptide fractions from protein hydrolysate of E. hirta have Shown also a cytotoxicity against a gastric carcinoma cell line (KATO-III, ATCC No. HTB103) at 100 μg peptides ml−1 [41] .

8.1. Anti-Diabetes

The following new prenylated flavonoids, Quercetrin, 3’,4’-Dimethoxyquercetin, Hirtacoumaroflavonoside and Hirtaflavonoside-B, isolated from methanolic extract of E. hirta were studied for their antidiabetic activity by Sheliya et al. [27] . They inhibited in vitro α-glucosidase with IC50 values of 0.151, 0.182, 0.022 and 0.071 mM, respectively. They also regulated the postprandial hyperglycemia in rats at 10 mg/kg. The work of Le et al. [25] on the effect of Quercetrin from ethanol extract of E. hirta, on endoplasmic reticulum stress-induced cell death in mouse pancreatic β-cell lines, revelated its strong cell-protective effect with the cell viability of 78 % at the dose of 10 µg/mL. Other flavonoids (Quercetin, rutin, myricitrin, cyanidin 3,5-O-diglucoside, Pelargonidin 3,5-diglucoside) and the terpenoids such as α-amyrine, β-amyrine, taraxerol have demonstrated a high binding affinity (<−8.0 kcal/mol) to protein relating diabetes Type 2 in silico [42] .

8.2. Anti-Viral

Myricitrin is a flavonoid from 50% ethanol/methanol extract of E. hirta. It inhibited Japanese encephalitis virus at 100 μM [28] . Galloylquinic acid (phenolic acid) was effective against nonstructural proteins (NS1, NS3) and envelope protein domain III of ZIKA virus in silico [43] . Euphorbianin and rutin are other flavonoids investigated in silico. They showed high binding affinity against protease Mpro, RNA-dependent RNA polymerase RdRp of SARS-CoV-2 [44] .

8.3. Anti-Inflammatory

The study of Shih et al. [35] showed that the anti-inflammatory effect of ethanolic extract of E. hirta, is mediated through its terpenoid component, β-amyrin. It blocked the iNOS protein functions (at 0.025 mg/ml) and the nitric oxide (NO) production (at 0.0125 mg/ml) on the LPS-induced RAW 264.7 cells. β-amyrin and other terpenoids (24-methyl encycloartenol and β-sitosterol) isolated from n-hexane extract of E. hirta aerial parts, exerted significant inhibition effects on TPA-induced inflammation in ear to the mice with ED50 value of 0.12, 0.26 and 0.14 mg/ear respectively [36] . The methanol extract of E. hirta aerial parts, rich with two flavonoids (Quercetrin, Rhamnetin) and two phenolic acids (Ferulic acid, Gallic acid), was standardized and designated as PM 251 by Subbiah [18] . PM 251 has proved to be a significant COX-2 (Cyclooxygenase) enzyme inhibitor in vitro. It was also revealed to be a good anti-inflammatory agent in two acute (turpentine-induced arthritis and formalin-induced experimental peritonitis) and the sub-acute (cotton pellet-induced granuloma) models of inflammation in the doses of 100 mg/kbw, 200 mg/kbw and 400 mg/kbw body weights when given orally to rats.

8.4. Anticancer

Afzelin, Quercetrin and Myricitrin are flavonol glycosides isolated from methanolic extract of E. hirta aerial parts. They exhibited a cytotoxic property against human epidermoid carcinoma KB 3-1 cells with IC50 values of 276.1, 88.2 and 156.4 µg/ml, respectively [24] . A mixture of two terpenoids, 25-hydroperoxycycloart-23-en-3β-ol and 24-hydroperoxycycloart-25-en-3β-ol, from CH2Cl2 extract of E. hirta leaves have demonstrated cytotoxicity activities against a human cancer cell line, colon carcinoma (HCT 116) at 4.8 μg/ml; and against non-small cell lung adenocarcinoma (A549) at 4.5 μg/ml [34] . According to Paulpandi et al. [45] , Quercetin is a flavonoid isolated from E. hirta leaves, which showed reduction in human breast adenocarcinoma MCF-7 cells viability with IC50 value of 2 μM.

8.5. Antimalaria

The flavonol glycosides, Afzelin, Quercetrin, and Myricitrin from methanolic extract of E. hirta aerial parts, have been reported to reduce the proliferation of Plasmodium falciparum with IC50 values of 1.1, 4.1 and 5.4 µg/ml respectively [24] . The findings of Shah et al. [46] also indicated that flavonoids such as Isorhamnetin and Pinocembrin had significant inhibitory activity against plasmepsin protease in silico approach.

8.6. Antimicrobial

According to the work of Ragasa and Cornelio [34] , three triterpenes isolated from CH2Cl2 extracts of E. hirta were found to exhibit antimicrobial activities. Indeed, Taraxerol from stems extract was active against Pseudomonas aeruginosa and Staphylococcus aureus at 30 mg. In addition, the mixture of 25-hydroperoxycycloart-23-en-3β-ol and 24-hydroperoxycycloart-25-en-3β-ol from leaves extract was active against the bacteria: P. aeruginosa, S. aureus, Escherichia coli and fungi: Candida albicans and Trichophyton mentagrophytes at 30 mg. Moreover, two flavonoids, Quercetin and Kaempferol, identified in the bound flavonoids from 80% hot methanol extract of stems extract, showed an activity against the bacteria: E. coli, P. aeruginosa, Proteus mirabilis, S. aureus and the fungi: Aspergillus flavus, Aspergillus niger, T. mentagrophytes and C. albicans at 1 mg/disc [22] . The evaluation of antibacterial and antifungal activities of two triterpenoids, Taraxerone and 11α, 12α-oxidotaraxerol isolated from petroleum ether extract of E. hirta, revealed their efficiency against Bacillus subtilis, B. cereus, B. megaterium, Sarcina lutea, S. aureus, E. coli, Shigella dysenteriae, S. sonnei, S. shiga, S. boydii, S. flexneriae, P. aeruginosa, Salmonella typhi, Klebsiella sp. Aspergillus flavus, A. niger, Penecillum sp. Trichoderma viride, C. albicans, Botryodiplodia theobromae with MIC value from 64 to 128 μg/ml [14] . The methanol extract of E. hirta aerial parts, have offered two antibacterial compounds, Caffeic acid (Phenolic acid) and Epicatechin 3-gallate (Flavonoid), which targeted both cell wall and cytoplasmic membrane of P. aeruginosa with MIC value at 15.6 and 31.3 µg/mL, respectively [12] [19] . The screening by TLC of ethyl acetate extract of E. hirta leaves, which had an effectiveness against MRSA: S.aureus B39 (MIC = 25mg/ml), showed that the anti-MRSA spots were identified as Hydroquinone (Diphenol) and O-coumaric acid (Phenolic acids) [15] . A hydrolyzable tannin, Euphorbin C, derived from E. hirta, was effective against Helicobacter pylori with MIC value from 25 to 50 µg/ml [33] .

8.7. Anti-Atherosclerosis

β-Amyrin, an active terpenoid of E. hirta, purchased from the extrasynthese (Taipei), inhibited the atherosclerotic initiation induced by pro-inflammatory cytokines in SVEC4-10 endothelial cells at 0.6 and 0.3 µM [47] .

8.8. Antidiarrhoeic

Quercetin is an antidiarrhoeic flavonoid constituent from acetone:water (7:3) extract of E. hirta. It decreased both the total number of faeces and the number of diarrhoeic faeces induced in mice by castor oil at content ranging from 12.5 to 100 mg/kg [13] .

8.9. Anti-Stress

The funding of Tiwari et al. [23] has revealed the anti-stress potential of Quercetin, a flavonoids isolated from hydroalcoholic extract of E. hirta leaves. Mice pretreated with this molecule at the dose of 25, 50 and 100 mg/kg showed significant improvement in the swimming time, a rise in the time spent in open arm and a decrease in the time spent in the closed arm, compared to the control group.

8.10. Anti-Asthmatic

Taraxerol is a triterpene isolated from ethanolic extract of E. Hirta stems. It possesses an anti-asthmatic property by the inhibition of the contractile effect of histamine in guinea pigs at 100 and 200 mg/kg [37] .

8.11. Anti-Thrombotic Disorders

The terpenoids, Hirtin isolated from latex of E. hirta, exhibited in vitro Azocaseinolytic and thrombin-like activities at 5 µg, gefibrinogenolytic and fibrinolytic properties at 2 µg [38] .

8.12. Antioxidant

Hydroxyl cinnamic acid derivatives are phenolic acids and antioxidants isolated from aqueous extract of E. hirta leaves. They exhibited an effective value of EC50 150 g/ml in the protective interaction with reference bovine serum albumin protein (BSA) against metal-catalyzed oxidation (MCO) system [20] . The following molecules Methyl-3-(3,5-ditertbutyl-4-hydroxyphenyl) propionate, a hydroxyphenylcarboxylic acid esters from methanol extract of leaves; and twenty new chebulic acid and brevifolincarboxylic acid derivatives (phenolic acids) from ethanol extract of plant aerial parts, acted as an antioxidant by DPPH radical scavenging activities in vitro with IC50 = 30.02 ppm and EC50 values from 2.2 to 15.8 μM respectively [21] [39] .

8.13. Anti-Snake Venom

The bioassay-guided fractionation of methanol extract of E. hita yielded Pyrogallol (triphenol) and Quercetrin (flavonoid), with protective effect against snake venom [16] [26] . Pyrogallol inhibited in vitro Naja naja venom protease activity at 1:40 w/w (venom:Pyrogallol). Concerning the quercetrin (QR), in vitro experiments indicated that protease, phospholipase-A2 and hemolytic activities of Naja naja venom were inhibited completely at a ratio of 1:20 w/w (venom:QR). A significant inhibition of hyaluronidase activity was also observed at 1:50 w/w (venom:QR).

In addition, in vivo study revealed that Quercetrin exhibited at 1:20 w/w, the inhibition of hemorrhage and edema induced in mice. It extended the survival time of mice injected with snake venom.

8.14. Anti-Hemorrhoid

Rutin, a flavonoid isolated from ethanol extract of E. hirta, showed remarkable healing on croton oil-inducing hemorrhoids in Wistar Albino rats at 100 mg/kg [29] .

9. Conclusion

In this review, we have summarized the structures and properties of 38 bioactive phytochemicals isolated from E. hirta. Our studies showed that this plant could be a promising source of novel drug candidates. Further investigations are necessary to understand the relationship existing between phytochemicals isolated and their activities.

Authors’ Contributions

Conceptualization: R.N.M. and S.E.K.; reviewed the literature and writing: all authors; validation investigation: R.N.M. All authors have read and approved the final manuscript.

Funding

This study received no external funding.

Conflicts of Interest

The authors declare no conflicts of interest regarding the publication of this paper.

References

[1] Ernst, M., Grace, O.M., Saslis-Lagoudakis, C.H., Nilsson, N., Simonsen, H.T. and Rønsted, N. (2015) Global Medicinal Uses of Euphorbia L. (Euphorbiaceae). Journal of Ethnopharmacology, 176, 90-101.
https://doi.org/10.1016/j.jep.2015.10.025
[2] Nacoulma, O.G. (1996) Medicinal Plants and Their Traditional Uses in Burkina Faso. Ph.D. Thesis, University of Ouagadougou, Ouagadougou, 328 p.
[3] Perumal, S., Pillai, S., Cai, L.W., Mahmud, R. and Ramanathan, S. (2012) Determination of Minimum Inhibitory Concentration of Euphorbia hirta (L.) Extracts by Tetrazolium Microplate Assay. Journal of Natural Products, 5, 68-76.
[4] Igoli, J.O., Ogaji, O.G., Tor-Anyiin, T.A. and Igoli, N.P. (2005) Traditional Medicine Practice amongst the Igede People of Nigeria. Part II. African Journal of Traditional, Complementary and Alternative Medicines, 2, 134-152.
https://doi.org/10.4314/ajtcam.v2i2.31112
[5] Nadembega, P., Boussim, J.I., Nikiema, J.B., Poli, F. and Antognoni, F. (2011) Medicinal Plants in Baskoure, Kourittenga Province, Burkina Faso: An Ethnobotanical Study. Journal of Ethnopharmacology, 133, 378-395.
https://doi.org/10.1016/j.jep.2010.10.010
[6] Zerbo, P., Millogo-Rasolodimby, J., Ouedraogo, O.N. and Van Damme, P. (2011) Plantes médicinales et pratiques médicales au Burkina Faso: Cas des Sanan. Bois et Forêts des Tropiques, 307, 41-53.
https://doi.org/10.19182/bft2011.307.a20481
[7] Al-Snafi, A.E. (2017) Pharmacology and Therapeutic Potential of Euphorbia hirta (Syn: Euphorbia pilulifera)—A Review. IOSR Journal of Pharmacy, 7, 7-20.
https://doi.org/10.9790/3013-0703010720
[8] Uddin, S., Billah, M. and Nuri, Z.N. (2019) Pharmacological Actions of Euphorbia hirta: A Review. International Journal of Horticulture and Food Science, 1, 84-89
[9] Ghosh, P., Chandreyi, G., Shaktijit, D., Chandrima, D., Suprodip, M. and Sirshendu, C. (2019) Botanical Description, Phytochemical Constituents and Pharmacological Properties of Euphorbia hirta Linn: A Review. International Journal of Health Sciences & Research, 9, 273-286.
[10] Kumar, S., Malhotra, R. and Kumar, D. (2010) Euphorbia hirta: Its Chemistry, Traditional and Medicinal Uses, and Pharmacological Activities. Pharmacognosy Reviews, 4, 58-61.
https://doi.org/10.4103/0973-7847.65327
[11] Rhasid, A.N.M.M., Mahmud, S., Towfique, N.M. and Monokesh, K.S. (2013) A Compendium Ethnopharmaceutical Riview on Euphorbia hirta L. Ayurpharm— International Journal of Ayurveda and Allied Sciences, 2, 14-21.
[12] Perumal, S., Mahmud, R. and Ramanathan, S. (2015) Anti-Infective Potential of Caffeic Acid and Epicatechin 3-Gallate Isolated from Methanol Extract of Euphorbia hirta (L.) against Pseudomonas aeruginosa. Natural Product Research: Formerly Natural Product Letters, 29, 1766-1769.
https://doi.org/10.1080/14786419.2014.999242
[13] Galvez, J., Zarzuelo, A., Crespo, M.E., Lorente, M.D., Ocete, M.A. and Jiménez, J. (1993) Antidiarrhoeic Activity of Euphorbia hirta Extract and Isolation of an Active Flavonoid Constituent. Planta Medica, 59, 333-336.
https://doi.org/10.1055/s-2006-959694
[14] Abu-Sayeed, M., Alib, M.A., Bhattacharjee, P.K., Islamb, A., Astaq, G.R.M., Khan, M. and Yeasmin, S. (2005) Biological Evaluation of Extracts and Triterpenoids of Euphorbia hirta. BiologicalSciences—PJSIR, 48, 122-125.
[15] Abdelkhalek, E.S., El-Hela, A.A., El-Kasaby, A.H., Sidkey, N.M., Desouky, E.M. and Abdelhaleem, H.H. (2018) Antibacterial Activity of Polygonum plebejum and Euphorbia hirta against Staphylococcus aureus (MRSA). Journal of Pure and Applied Microbiology, 12, 2205-2216.
https://doi.org/10.22207/JPAM.12.4.60
[16] Gopi, K., Renu, K., Vishwanath, B.S. and Jayaraman, G. (2015) Protective Effect of Euphorbia hirta and Its Components against Snake venom Induced Lethality. Journal of Ethnopharmacology, 165, 180-190.
https://doi.org/10.1016/j.jep.2015.02.044
[17] Chen, L. (1991) Polyphenols from Leaves of Euphorbia hirta L. China Journal of Chinese Materia Medica, 16, 38-39, 64. (In Chinese)
[18] Subbiah, V. (2007) Anti-Inflammatory Properties of a Standardized Extract from euphorbia hirta (PM-251) Activity and for Treating Conditions of Inflammation. US No. US-2007248694-A1.
[19] Perumal, S., Mahmud, R. and Ismail, S. (2017) Mechanism of Action of Isolated Caffeic Acid and Epicatechin 3-Gallate from Euphorbia hirta against Pseudomonas aeruginosa. Pharmacognosy Magazine, 13, S311-S315.
https://doi.org/10.4103/pm.pm_309_15
[20] Sharma, N.K. and Prasad, R. (2008) Oxidative Injury to Protein and Their Protection by Phenolic Acid Antioxidants from Euphorbia hirta Leaves. Journal of Biotechnology, 136, S720.
https://doi.org/10.1016/j.jbiotec.2008.07.1713
[21] Yang, Z.-N., Su, B.-J., Wang, Y.-Q., Liao, H.-B., Chen, Z.-F. and Liang, D. (2019) Isolation, Absolute Configuration, and Biological Activities of Chebulic Acid and Brevifolincarboxylic Acid Derivatives from Euphorbia hirta. Journal of Natural Products, 83, 985-995.
https://doi.org/10.1021/acs.jnatprod.9b00877
[22] Singh, G. and Kumar, P. (2013) Phytochemical Study and Screening for Antimicrobial Activity of Flavonoids of Euphorbia hirta. International Journal of Applied and Basic Medical Research, 3, 111-116.
https://doi.org/10.4103/2229-516X.117082
[23] Tiwari, N., Mishra, A., Bhatt, G. and Chaudhary, A. (2015) Anti-Stress Activity of a Bioflavanoid: Quercetin from Euphorbia hirta. Journal of Pharmaceutical Research International, 6, 68-75.
https://doi.org/10.9734/BJPR/2015/16143
[24] Liu, Y., Murakami, N., Ji, H., Abreu, P. and Zhang, S. (2007) Antimalarial Flavonol Glycosides from Euphorbia hirta. Pharmaceutical Biology, 45, 278-281.
https://doi.org/10.1080/13880200701214748
[25] Le, B.T., Le, D.T., Nguyen, T.T., Nguyen, T.Q.C., Quetin, L.J. and Bui, B.H.T. (2018) The Protective Effect Of Some Extracts and Isolated Compounds from Euphorbia hirta on Pancreatic β-Cells MIN6. Vietnam Journal of Science and Technology, 56, 163-170.
https://doi.org/10.15625/2525-2518/56/4A/12753
[26] Gopi, K., Anbarasu, K., Renu, K., Jayanthi, S., Vishwanath, B.S. and Jayaraman, G. (2016) Quercetin-3-O-Rhamnoside from Euphorbia hirta Protects against Snake Venom Induced Toxicity. Biochimica et Biophysica Acta (BBA)—General Subjects, 1860, 1528-1540.
https://doi.org/10.1016/j.bbagen.2016.03.031
[27] Sheliya, M.A., Rayhana, B., Ali, A., Pillai, K.K., Aeri, V., Sharma, M. and Mir, S.R. (2015) Inhibition of α-Glucosidase by New Prenylated Flavonoids from euphorbia hirta L. Herb. Journal of Ethnopharmacology, 176, 1-8.
https://doi.org/10.1016/j.jep.2015.10.018
[28] Tayone, W.C., Ishida, K., Goto, S., Tayone, J.C., Arakawa, M., Morita, E. and Hashimoto, M. (2020) Anti-Japanese Encephalitis Virus (JEV) Activity of Triterpenes and Flavonoids from Euphorbia hirta. Philippine Journal of Science, 149, 603-613.
https://doi.org/10.56899/149.03.13
[29] Kori, Y.S., Yogi, B. and Gupta, S. (2020) Antihaemorrhoid Activity of Isolated and Semi-Synthesized Rutin derivative from Euphorbia hirta Linn. Research Journal of Pharmacy and Technology, 13, 1333-1338.
https://doi.org/10.5958/0974-360X.2020.00246.2
[30] Aleksandrov, M., Maksimova, V. and Gudeva, L.K. (2019) Review of the Anticancer and Cytotoxic Activity of some Species from Genus Euphorbia. Agriculturae Conspectus Scientificus, 84, 1-5.
[31] Wu, Y., Qu, W., Geng, D., Liang, J.-Y. and Luo, Y.-L. (2012) Phenols and Flavonoids from the Aerial Part of Euphorbia hirta. Chinese Journal of Natural Medicines, 10, 40-42.
https://doi.org/10.3724/SP.J.1009.2012.00040
[32] Aqil, M. (1999) Euphorbianin, a New Glycoside from Euphorbia hirta Linn. Global Journal of Pure and Applied Science, 5, 371-374.
[33] Funatogawa, K., Hayashi, S., Shimomura, H., Yoshida, T., Hatano, T., Ito, H. and Hirai, Y. (2004) Antibacterial Activity of Hydrolyzable Tannins Derived from Medicinal Plants against Helicobacter pylori. Microbiology and Immunology, 48, 251-261.
https://doi.org/10.1111/j.1348-0421.2004.tb03521.x
[34] Ragasa, C.Y. and Cornelio, K.B. (2013) Triterpenes from Euphorbia hirta and Their Cytotoxicity. Chinese Journal of Natural Medicines, 11, 528-533.
https://doi.org/10.1016/S1875-5364(13)60096-5
[35] Shih, M.-F., Cheng, Y.-D., Shen, C.-R. and Chemg, J.-Y. (2010) A Molecular Pharmacology Study into the Anti-Inflammatory Actions of Euphorbia hirta L. on the LPS-Induced RAW 264.7 Cells through Selective iNOS Protein Inhibition. Journal of Natural Medicines, 64, 330-335.
https://doi.org/10.1007/s11418-010-0417-6
[36] Martínez-Vázquez, M., Ramírez Apan, T.O., Lazcano, M.E. and Bye, R. (1999) Anti-Inflammatory Active Compounds from the N-Hexane Extract of Euphorbia hirta. Revista de la Sociedad Química de México, 43, 103-105.
[37] Prachi, S. and Pradeep, T. (2014) 13α-Methyl-27-Norolean-14-en-3β-ol, a Triterpeneisolated from the Stem of Euphorbia hirta (Linn) Possess an Anti-Asthmatic Properties. Research Journal of Chemical Sciences, 4, 21-26.
[38] Patel, G.K., Kawale, A.A. and Sharma, A.K. (2012) Purification and Physicochemical Characterization of A Serine Protease with Fibrinolytic Activity from Latex of a Medicinal Herb Euphorbia hirta. Plant Physiology and Biochemistry, 52, 104-111.
https://doi.org/10.1016/j.plaphy.2011.12.004
[39] Eli, M. and Tukiran, T. (2017) Antioxidant Activity and Identification of Isolated Compounds from Methanol Extract of Plant Euphorbia hirta. UNESA Journal of Chemistry, 6, 1-5.
[40] Zhang, L., Wang, X.-L., Wang, B., Zhang, L.-T., et al. (2020) Lignans from Euphorbiahirta L. Natural Product Research, 36, 26-36.
https://doi.org/10.1080/14786419.2020.1761358
[41] Yodyingyong, S., Chaichana, C., Nuchsuk, C., Roytrakul, S., T-Thienprasert, N.P. and Ratanapo, S. (2013) Partial Purification of Cytotoxic Peptides against Gastric Cancer Cells from Protein Hydrolysate of Euphorbia hirta Linn. ICBMB 2013: International Conference on Biochemistry and Molecular Biology, Vol. 7, Osaka, 2-6 June 2013, 991-994.
https://www.researchgate.net/publication/267040295
[42] Trinh, Q. and Le, L. (2014) An Investigation of Antidiabetic Activities of bIoactive Compounds in Euphorbia hirta Linn Using Molecular Docking and Pharmacophore. Medicinal Chemistry Research, 23, 2033-2045.
https://doi.org/10.1007/s00044-013-0794-y
[43] Sangeetha, K., Sharmila, S. and Sharmila, D. (2020) Admet and DFT Studies of Compounds from Euphorbia Hirta and Bacopa Monnieri to Zika Virus Structural and Non-Structural Proteins. UGC Care Journal, 31, 98-103.
[44] Parmar, G., Shah, A., Shah, S. and Seth, A.K. (2021) Identification of Bioactive Phytoconstituents from the Plant Euphorbia hirta as Potential Inhibitor of SARS-CoV-2: An in-Silico Approach. Biointerface Research in Applied Chemistry, 12, 1385-1396.
https://doi.org/10.33263/BRIAC122.13851396
[45] Paulpandi, M., Kavithaa, K., Sumathi, S. and Padma, P.R. (2013) Increased Anticancer Efficacy by the Combined Administration of Quercetin in Multidrug Resistant Breast Cancer Cells. Annals of Oncology, 24, III19.
https://doi.org/10.1093/annonc/mdt081.4
[46] Shah, A.P., Parmar, G.R., Sailor, G.U. and Seth, A.K. (2019) Antimalarial Phytochemicals Identification from Euphorbia hirta against Plasmepsin Protease: An in-Silico Approach. Folia Medica, 61, 584-593.
https://doi.org/10.3897/folmed.61.e47965
[47] Shih, M.F. and Cherng, J.Y. (2014) Reduction of Adhesion Molecule Production and Alteration of eNOS and Endothelin-1 mRNA Expression in Endothelium by Euphorbia hirta L. through Its Beneficial β-Amyrin Molecule. Molecules, 19, 10534-10545.
https://doi.org/10.3390/molecules190710534

Copyright © 2024 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.